PHAT

PhathomA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

PHAT vs peer average

95/100

PHAT vs. peer average (A vs. D)

Grade spread

B 1 · C 2 · D 2 · F 3

Graded peers loaded

Coverage

8 graded

100% of tracked

Peer overview

CTMX is the first available peer comparator.

Similar market capitalization and broad biotechnology classification, but CytomX lacks verified gastrointestinal-commercial or indication overlap in the packet; valuation comparability is weak.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerCTMXCytomX Therapeutics

PHAT

Phathom

CTMX

CytomX Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs CTMX

PHAT / CTMX

Grade Position

Above peers

PHAT vs. peer average (A vs. D)

95/100

Momentum

CTMX

Value

PHAT

Sentiment

PHAT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs PHAT

CTMX

60/100

FDMT

20/100

OCS

Oculis Holding AG Common

60/100

RGNX

REGENXBIO Inc Common

40/100

STTK

Shattuck Labs Inc Common

80/100

CTMX is the first peer returned for this comparison set.